MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- FORTIS HEALTHCARE
FORTIS HEALTHCARE Share Price 
(FORTIS)
Here is the latest stock price and chart of FORTIS HEALTHCARE. For more details, see the FORTIS HEALTHCARE company fact sheet and quarterly results.
| Live BSE Quotes | Jun 19, 2019 02:11:00 PM | ||
|---|---|---|---|
| Price (Rs)131.25 | Open (Rs) 131.10 | High (Rs) 133.30 | Low (Rs) 130.70 |
| % Change0.42 | Volume 101,199 | Value (Rs) 13,282,369 | 52-Week H/L 153.70 / 121.35 |
| Live NSE Quotes | Jun 19, 2019 2:14:51 PM | ||
|---|---|---|---|
| Price (Rs)131.40 | Open (Rs) 131.05 | High (Rs) 133.20 | Low (Rs) 130.45 |
| % Change0.27 | Volume 524,813 | Value (Rs) 69,186,098 | 52-Week H/L 153.00 / 121.25 |
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* -12.60 | P/E Ratio (x) NM | Market Cap (Rs m) 60,739.88 | P/BV (x) 1.50 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
Peer Group:
Quote & GraphS&P BSE SENSEX
PERIOD - Advanced Charts new
- Charts by TradingView
FORTIS HEALTHCARE Share Price Today:
FORTIS HEALTHCARE share price is up 0.4% to Rs 131.3 on the BSE. On the NSE, the FORTIS HEALTHCARE share price is up 0.3% to Rs 131.4. The total volume of shares traded is 0.6 m.
Overall, the benchmark S&P BSE SENSEX is trading at 39,040.2 (down 0.0%).
Over the last 30 days, the FORTIS HEALTHCARE share price is up 3.4%. And over the last one year, FORTIS HEALTHCARE share price is down 4.5%.
|
| |
Today's Market
Indian Indices Turn Volatile; Yes Bank Slips 5%(12:30 pm)
Share markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the consumer durables sector.
Related Views On News
FORTIS HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Up 80.1% (Quarterly Result Update)
May 27, 2019 | Updated on May 27, 2019For the quarter ended March 2019, FORTIS HEALTHCARE has posted a net profit of Rs 2 bn (up 80.1% YoY). Sales on the other hand came in at Rs 12 bn (up 9.0% YoY). Read on for a complete analysis of FORTIS HEALTHCARE's quarterly results.
FORTIS HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 869.4% (Quarterly Result Update)
Feb 22, 2019 | Updated on Feb 22, 2019For the quarter ended December 2018, FORTIS HEALTHCARE has posted a net profit of Rs 2 bn (down 869.4% YoY). Sales on the other hand came in at Rs 11 bn (down 1.6% YoY). Read on for a complete analysis of FORTIS HEALTHCARE's quarterly results.
FORTIS HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)
Dec 20, 2018 | Updated on Dec 20, 2018Here's an analysis of the annual report of FORTIS HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FORTIS HEALTHCARE. Also includes updates on the valuation of FORTIS HEALTHCARE.
MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)
Mar 13, 2019Should you subscribe to the IPO of MSPC Limited?
Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)
Mar 14, 2018Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?
More Views on NewsMost Popular
7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)
Jun 13, 2019We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?
The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)
Jun 11, 2019One chart that predicted the NBFC crisis back in 2016.
Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)
Jun 6, 2019Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...
Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)
Jun 12, 2019This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.
Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)
Jun 10, 2019The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.
MoreTRACK FORTIS HEALTHCARE
- Track your investment in FORTIS HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON FORTIS HEALTHCARE
FORTIS HEALTHCARE - INDRAPRASTHA MEDICAL COMPARISON
COMPARE FORTIS HEALTHCARE WITH
OTHER USEFUL LINKS
MARKET STATS
|
| |
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.